184 related articles for article (PubMed ID: 17045646)
1. Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes.
Boey D; Heilbronn L; Sainsbury A; Laybutt R; Kriketos A; Herzog H; Campbell LV
Neuropeptides; 2006 Oct; 40(5):317-24. PubMed ID: 17045646
[TBL] [Abstract][Full Text] [Related]
2. [The response of serum ghrelin and PYY to oral glucose and steamed-bread tolerance test in nonobese and obese patients with type 2 diabetes].
An ZM; Zhang L; Zhang M; Huang MJ; Xiong ZY; Zhang GF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):772-5. PubMed ID: 19024311
[TBL] [Abstract][Full Text] [Related]
3. High serum fasting peptide YY (3-36) is associated with obesity-associated insulin resistance and type 2 diabetes.
Ukkola OH; Puurunen VP; Piira OP; Niva JT; Lepojärvi ES; Tulppo MP; Huikuri HV
Regul Pept; 2011 Oct; 170(1-3):38-42. PubMed ID: 21635925
[TBL] [Abstract][Full Text] [Related]
4. Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes.
Viardot A; Heilbronn LK; Herzog H; Gregersen S; Campbell LV
Int J Obes (Lond); 2008 Jun; 32(6):943-8. PubMed ID: 18317469
[TBL] [Abstract][Full Text] [Related]
5. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
Herlihy OM; Barrow BA; Grant PJ; Levy JC
Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
[TBL] [Abstract][Full Text] [Related]
7. Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband.
Tripathy D; Lindholm E; Isomaa B; Saloranta C; Tuomi T; Groop L
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1297-303. PubMed ID: 12954593
[TBL] [Abstract][Full Text] [Related]
8. Is postprandial hypertriglyceridaemia in relatives of type 2 diabetic subjects a consequence of insulin resistance?
Kriketos A; Milner KL; Denyer G; Campbell L
Eur J Clin Invest; 2005 Feb; 35(2):117-25. PubMed ID: 15667583
[TBL] [Abstract][Full Text] [Related]
9. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance in the first-degree relatives of persons with type 2 diabetes.
Straczkowski M; Kowalska I; Stepień A; Dzienis-Straczkowska S; Szelachowska M; Kinalska I; Krukowska A; Konicka M
Med Sci Monit; 2003 May; 9(5):CR186-90. PubMed ID: 12761455
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients.
Alberti L; Gilardini L; Girola A; Moro M; Cavagnini F; Invitti C
Diabetes Obes Metab; 2007 May; 9(3):344-9. PubMed ID: 17391161
[TBL] [Abstract][Full Text] [Related]
12. PYY transgenic mice are protected against diet-induced and genetic obesity.
Boey D; Lin S; Enriquez RF; Lee NJ; Slack K; Couzens M; Baldock PA; Herzog H; Sainsbury A
Neuropeptides; 2008 Feb; 42(1):19-30. PubMed ID: 18164057
[TBL] [Abstract][Full Text] [Related]
13. Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes.
Peake PW; Kriketos AD; Campbell LV; Charlesworth JA
Int J Obes (Lond); 2005 Apr; 29(4):429-35. PubMed ID: 15111984
[TBL] [Abstract][Full Text] [Related]
14. The preservation of insulin sensitivity in obese women without diabetes.
Ngarmukos C; Chanprasertyothin S; Puavilai G; Ongphiphadhanakul B
J Med Assoc Thai; 2008 May; 91(5):659-64. PubMed ID: 18672628
[TBL] [Abstract][Full Text] [Related]
15. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
[TBL] [Abstract][Full Text] [Related]
16. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes.
Cnop M; Vidal J; Hull RL; Utzschneider KM; Carr DB; Schraw T; Scherer PE; Boyko EJ; Fujimoto WY; Kahn SE
Diabetes Care; 2007 Mar; 30(3):677-82. PubMed ID: 17327340
[TBL] [Abstract][Full Text] [Related]
17. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
18. GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects.
Fernández-García JC; Murri M; Coin-Aragüez L; Alcaide J; El Bekay R; Tinahones FJ
Clin Endocrinol (Oxf); 2014 May; 80(5):671-6. PubMed ID: 23573808
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects.
Hu C; Jia W; Fang Q; Zhang R; Wang C; Lu J; Xiang K
Diabet Med; 2006 Dec; 23(12):1307-12. PubMed ID: 17116180
[TBL] [Abstract][Full Text] [Related]
20. A lesser postprandial suppression of plasma ghrelin in Prader-Willi syndrome is associated with low fasting and a blunted postprandial PYY response.
Giménez-Palop O; Giménez-Pérez G; Mauricio D; González-Clemente JM; Potau N; Berlanga E; Trallero R; Laferrère B; Caixàs A
Clin Endocrinol (Oxf); 2007 Feb; 66(2):198-204. PubMed ID: 17223988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
